Peptide directoryReproductive

INSL3

The Leydig cell’s hormone that pulls the testes down before birth.

Where it comes from

Made in
Leydig cells of the testis; in women, theca cells of the ovary at a far lower level
Sent out by
Steady, in proportion to Leydig cell number; stimulated by LH over weeks rather than minutes
Acts on
  • The gubernaculum (the cord that guides testicular descent)
  • Germ cells
  • Bone

What it does

  • Makes the gubernaculum swell so the testes descend into the scrotum; mice without the gene have undescended testes 1
  • A constant readout of how many Leydig cells a man has, unlike testosterone, which swings through the day 2
  • Men carrying a faulty RXFP2 receptor have lower bone mass, which is the evidence that it acts on bone 3

In medicine

  • Measured in research as a Leydig cell marker in ageing, hypogonadism and after chemotherapy 2
  • Mutations of INSL3 or RXFP2 are a rare cause of undescended testes, found in a small minority of cases 4

Beyond the body’s own use

  • Nobody is given INSL3. No preparation of it exists, and undescended testes are treated by surgery, with hCG the only hormonal option
  • The interest is as a test rather than a treatment: because the level follows Leydig cell number and not the hour of the day, a single blood sample is being studied as a measure of testicular capacity in ageing men 2

Sources

  1. Nef and Parada, Cryptorchidism in mice mutant for Insl3, Nature Genetics 1999
  2. Anand-Ivell et al., Age, hormonal and lifestyle factors and the Leydig cell biomarker INSL3, Andrology 2022
  3. Ferlin et al., Mutations in the insulin-like factor 3 receptor are associated with osteoporosis, Journal of Bone and Mineral Research 2008
  4. Ferlin et al., Genetic alterations associated with cryptorchidism, JAMA 2008

This card describes what a medicine is for and what the evidence says; it recommends nothing. Talk to your clinician about anything you read here.